Martha Q. Lacy

49.3k citations
554 papers · 25.4k indexed · 5 hit papers · h-index 78
Topics
Multiple Myeloma Research and Treatments (336 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (193 papers)Protein Degradation and Inhibitors (106 papers)

In The Last Decade

Martha Q. Lacy

537 papers receiving 24.8k citations

Hit Papers

Improved survival in multiple myeloma and the impact of n...20032026201020182007200320132012200450010001.5k

Peers

Martha Q. Lacy
Comparison fields: 5 of 152
  • Molecular Biology 16.8k
  • Hematology 15.8k
  • Oncology 9.4k
  • Genetics 5.2k
  • Epidemiology 2.0k
Replace Philip R. Greipp with:
Philip R. Greipp United States
Shaji Kumar United States
Rafaël Fonseca United States
Suzanne R. Hayman United States
Morie A. Gertz United States
Angela Dispenzieri United States
Thomas E. Witzig United States
Hartmut Goldschmidt Germany
Ola Landgren United States
Tiziano Barbui Italy
Martha Q. Lacy relative to Philip R. Greipp United States Philip R. Greipp's profile →
Citations per field
00.5×1.5×2.3×
Philip R. Greipp · 1×
Citations per year

Countries citing papers authored by Martha Q. Lacy

Since Specialization
Citations

This map shows the geographic impact of Martha Q. Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Q. Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Q. Lacy more than expected).

Fields of papers citing papers by Martha Q. Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Q. Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Q. Lacy. The network helps show where Martha Q. Lacy may publish in the future.

Co-authorship network of co-authors of Martha Q. Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Q. Lacy. A scholar is included among the top collaborators of Martha Q. Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Q. Lacy. Martha Q. Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 6
4 1
5 32
6 12
7 14
8 13
9 31
10 12
11 46
12 22
13 120
14 102
15 121
16 226
17 195
18 25
19 52
20 69

About Martha Q. Lacy

Martha Q. Lacy is a scholar working on Hematology, Genetics and Oncology, having authored 554 papers that have together received 25.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (336 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (193 papers) and Protein Degradation and Inhibitors (106 papers). The work is most often cited by research in Hematology (15.8k citations), Genetics (5.2k citations) and Oncology (9.4k citations). Martha Q. Lacy has collaborated with scholars based in United States, Canada and Saudi Arabia. Frequent co-authors include Morie A. Gertz, Angela Dispenzieri, S. Vincent Rajkumar, Robert A. Kyle, John A. Lust, Philip R. Greipp, Shaji Kumar, Suzanne R. Hayman, Thomas E. Witzig and Francis K. Buadi. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026